Search
Search Results
##search.searchResults.foundPlural##
-
THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS
2691PDF: 1049HTML: 1888 -
PROPHYLAXIS OF MALARIA
2954PDF: 992HTML: 17772Figures SChwartz: 148 -
Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs
1540PDF: 755HTML: 799tile page: 146Table 1: 149 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1620PDF: 623HTML: 2414 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3218PDF: 1273HTML: 6172 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
774PDF: 908Suppl. Files: 112HTML: 62 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4242PDF: 1449HTML: 1531Untitled: 210 -
Severe Acute Hepatitis B Treated with Entecavir
1449PDF: 743HTML: 2452Figure: 152Title page: 157disclosure: 92 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1215PDF: 514HTML: 22992 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
807PDF: 477HTML: 1283 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
901PDF: 448HTML: 63 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2313PDF: 887HTML: 486 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
5936PDF: 3092HTML: 8988Figure Malaria Ricci: 207 -
-
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1024PDF: 524HTML: 1676Figures: 147Fifures Sanz: 156tables Sanz: 163Untitled: 157 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1447PDF: 1132HTML: 171 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3244PDF: 1208HTML: 2175 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3028PDF: 1772HTML: 3540 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2110PDF: 1158HTML: 3682 -
Stroke in a patient with tuberculous meningitis and HIV infection
1535PDF: 771HTML: 1707figure 1: 138 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
890PDF: 558HTML: 2178Cover Letter: 174 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2075PDF: 842HTML: 300 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
788PDF: 524HTML: 4005 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1800PDF: 660HTML: 224 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3958PDF: 1011HTML: 3556Untitled: 163Cneo. Fig.1: 97Untitled: 89Untitled: 110Untitled: 111 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2445PDF: 841HTML: 2109 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2401PDF: 759HTML: 1721 -
Spontaneous rupture of malarial spleen: report of two cases
769PDF: 393HTML: 2856jdoe, cover letter.doc: 162







